IBDEI01P ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1671,2)
 ;;=^5007796
 ;;^UTILITY(U,$J,358.3,1672,0)
 ;;=I73.1^^8^128^91
 ;;^UTILITY(U,$J,358.3,1672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1672,1,3,0)
 ;;=3^Thromboangiitis Obliterans
 ;;^UTILITY(U,$J,358.3,1672,1,4,0)
 ;;=4^I73.1
 ;;^UTILITY(U,$J,358.3,1672,2)
 ;;=^5007798
 ;;^UTILITY(U,$J,358.3,1673,0)
 ;;=I73.9^^8^128^83
 ;;^UTILITY(U,$J,358.3,1673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1673,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,1673,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,1673,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,1674,0)
 ;;=I74.01^^8^128^85
 ;;^UTILITY(U,$J,358.3,1674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1674,1,3,0)
 ;;=3^Saddle Embolus of Abdominal Aorta
 ;;^UTILITY(U,$J,358.3,1674,1,4,0)
 ;;=4^I74.01
 ;;^UTILITY(U,$J,358.3,1674,2)
 ;;=^340522
 ;;^UTILITY(U,$J,358.3,1675,0)
 ;;=I74.09^^8^128^10
 ;;^UTILITY(U,$J,358.3,1675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1675,1,3,0)
 ;;=3^Arterial Embolism/Thrombosis of Abdominal Aorta NEC
 ;;^UTILITY(U,$J,358.3,1675,1,4,0)
 ;;=4^I74.09
 ;;^UTILITY(U,$J,358.3,1675,2)
 ;;=^340523
 ;;^UTILITY(U,$J,358.3,1676,0)
 ;;=I74.11^^8^128^70
 ;;^UTILITY(U,$J,358.3,1676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1676,1,3,0)
 ;;=3^Embolism/Thrombosis of Thoracic Aorta
 ;;^UTILITY(U,$J,358.3,1676,1,4,0)
 ;;=4^I74.11
 ;;^UTILITY(U,$J,358.3,1676,2)
 ;;=^269787
 ;;^UTILITY(U,$J,358.3,1677,0)
 ;;=I74.2^^8^128^73
 ;;^UTILITY(U,$J,358.3,1677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1677,1,3,0)
 ;;=3^Embolism/Thrombosis of Upper Extremity Arteries
 ;;^UTILITY(U,$J,358.3,1677,1,4,0)
 ;;=4^I74.2
 ;;^UTILITY(U,$J,358.3,1677,2)
 ;;=^5007801
 ;;^UTILITY(U,$J,358.3,1678,0)
 ;;=I74.3^^8^128^68
 ;;^UTILITY(U,$J,358.3,1678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1678,1,3,0)
 ;;=3^Embolism/Thrombosis of Lower Extremity Arteries
 ;;^UTILITY(U,$J,358.3,1678,1,4,0)
 ;;=4^I74.3
 ;;^UTILITY(U,$J,358.3,1678,2)
 ;;=^5007802
 ;;^UTILITY(U,$J,358.3,1679,0)
 ;;=I74.5^^8^128^67
 ;;^UTILITY(U,$J,358.3,1679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1679,1,3,0)
 ;;=3^Embolism/Thrombosis of Iliac Artery
 ;;^UTILITY(U,$J,358.3,1679,1,4,0)
 ;;=4^I74.5
 ;;^UTILITY(U,$J,358.3,1679,2)
 ;;=^269792
 ;;^UTILITY(U,$J,358.3,1680,0)
 ;;=I74.8^^8^128^66
 ;;^UTILITY(U,$J,358.3,1680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1680,1,3,0)
 ;;=3^Embolism/Thrombosis of Arteries NEC
 ;;^UTILITY(U,$J,358.3,1680,1,4,0)
 ;;=4^I74.8
 ;;^UTILITY(U,$J,358.3,1680,2)
 ;;=^5007804
 ;;^UTILITY(U,$J,358.3,1681,0)
 ;;=I77.0^^8^128^12
 ;;^UTILITY(U,$J,358.3,1681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1681,1,3,0)
 ;;=3^Arteriovenous Fistula,Acquired
 ;;^UTILITY(U,$J,358.3,1681,1,4,0)
 ;;=4^I77.0
 ;;^UTILITY(U,$J,358.3,1681,2)
 ;;=^46674
 ;;^UTILITY(U,$J,358.3,1682,0)
 ;;=I77.1^^8^128^86
 ;;^UTILITY(U,$J,358.3,1682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1682,1,3,0)
 ;;=3^Stricture of Artery
 ;;^UTILITY(U,$J,358.3,1682,1,4,0)
 ;;=4^I77.1
 ;;^UTILITY(U,$J,358.3,1682,2)
 ;;=^114763
 ;;^UTILITY(U,$J,358.3,1683,0)
 ;;=I77.3^^8^128^11
 ;;^UTILITY(U,$J,358.3,1683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1683,1,3,0)
 ;;=3^Arterial Fibromuscular Dysplasia
 ;;^UTILITY(U,$J,358.3,1683,1,4,0)
 ;;=4^I77.3
 ;;^UTILITY(U,$J,358.3,1683,2)
 ;;=^5007812
 ;;^UTILITY(U,$J,358.3,1684,0)
 ;;=I77.6^^8^128^13
 ;;^UTILITY(U,$J,358.3,1684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1684,1,3,0)
 ;;=3^Arteritis,Unspec
 ;;^UTILITY(U,$J,358.3,1684,1,4,0)
 ;;=4^I77.6
 ;;^UTILITY(U,$J,358.3,1684,2)
 ;;=^5007813
 ;;^UTILITY(U,$J,358.3,1685,0)
 ;;=I82.90^^8^128^71
 ;;^UTILITY(U,$J,358.3,1685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1685,1,3,0)
 ;;=3^Embolism/Thrombosis of Unspec Vein,Acute
 ;;^UTILITY(U,$J,358.3,1685,1,4,0)
 ;;=4^I82.90
 ;;^UTILITY(U,$J,358.3,1685,2)
 ;;=^5007940
 ;;^UTILITY(U,$J,358.3,1686,0)
 ;;=I82.91^^8^128^72
 ;;^UTILITY(U,$J,358.3,1686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1686,1,3,0)
 ;;=3^Embolism/Thrombosis of Unspec Vein,Chronic
 ;;^UTILITY(U,$J,358.3,1686,1,4,0)
 ;;=4^I82.91
 ;;^UTILITY(U,$J,358.3,1686,2)
 ;;=^5007941
 ;;^UTILITY(U,$J,358.3,1687,0)
 ;;=I87.2^^8^128^96
 ;;^UTILITY(U,$J,358.3,1687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1687,1,3,0)
 ;;=3^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,1687,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,1687,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,1688,0)
 ;;=I82.0^^8^128^51
 ;;^UTILITY(U,$J,358.3,1688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1688,1,3,0)
 ;;=3^Budd-Chiari Syndrome
 ;;^UTILITY(U,$J,358.3,1688,1,4,0)
 ;;=4^I82.0
 ;;^UTILITY(U,$J,358.3,1688,2)
 ;;=^5007846
 ;;^UTILITY(U,$J,358.3,1689,0)
 ;;=I82.1^^8^128^92
 ;;^UTILITY(U,$J,358.3,1689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1689,1,3,0)
 ;;=3^Thrombophlebitis Migrans
 ;;^UTILITY(U,$J,358.3,1689,1,4,0)
 ;;=4^I82.1
 ;;^UTILITY(U,$J,358.3,1689,2)
 ;;=^5007847
 ;;^UTILITY(U,$J,358.3,1690,0)
 ;;=I82.3^^8^128^69
 ;;^UTILITY(U,$J,358.3,1690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1690,1,3,0)
 ;;=3^Embolism/Thrombosis of Renal Vein
 ;;^UTILITY(U,$J,358.3,1690,1,4,0)
 ;;=4^I82.3
 ;;^UTILITY(U,$J,358.3,1690,2)
 ;;=^269818
 ;;^UTILITY(U,$J,358.3,1691,0)
 ;;=I87.1^^8^128^95
 ;;^UTILITY(U,$J,358.3,1691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1691,1,3,0)
 ;;=3^Vein Compression
 ;;^UTILITY(U,$J,358.3,1691,1,4,0)
 ;;=4^I87.1
 ;;^UTILITY(U,$J,358.3,1691,2)
 ;;=^269850
 ;;^UTILITY(U,$J,358.3,1692,0)
 ;;=T82.818A^^8^128^65
 ;;^UTILITY(U,$J,358.3,1692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1692,1,3,0)
 ;;=3^Embolism of Vascular Prosthetic Device/Implant/Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,1692,1,4,0)
 ;;=4^T82.818A
 ;;^UTILITY(U,$J,358.3,1692,2)
 ;;=^5054917
 ;;^UTILITY(U,$J,358.3,1693,0)
 ;;=T82.828A^^8^128^74
 ;;^UTILITY(U,$J,358.3,1693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1693,1,3,0)
 ;;=3^Fibrosis of Vascular Prosthetic Device/Implant/Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,1693,1,4,0)
 ;;=4^T82.828A
 ;;^UTILITY(U,$J,358.3,1693,2)
 ;;=^5054923
 ;;^UTILITY(U,$J,358.3,1694,0)
 ;;=T82.868A^^8^128^93
 ;;^UTILITY(U,$J,358.3,1694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1694,1,3,0)
 ;;=3^Thrombosis of Vascular Prosthetic Device/Implant/Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,1694,1,4,0)
 ;;=4^T82.868A
 ;;^UTILITY(U,$J,358.3,1694,2)
 ;;=^5054947
 ;;^UTILITY(U,$J,358.3,1695,0)
 ;;=I08.0^^8^129^5
 ;;^UTILITY(U,$J,358.3,1695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1695,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral and Aortic Valves
 ;;^UTILITY(U,$J,358.3,1695,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,1695,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,1696,0)
 ;;=I05.0^^8^129^8
 ;;^UTILITY(U,$J,358.3,1696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1696,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,1696,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,1696,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,1697,0)
 ;;=I05.1^^8^129^7
 ;;^UTILITY(U,$J,358.3,1697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1697,1,3,0)
 ;;=3^Rheumatic Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,1697,1,4,0)
 ;;=4^I05.1
 ;;^UTILITY(U,$J,358.3,1697,2)
 ;;=^269568
 ;;^UTILITY(U,$J,358.3,1698,0)
 ;;=I05.2^^8^129^9
 ;;^UTILITY(U,$J,358.3,1698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1698,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,1698,1,4,0)
 ;;=4^I05.2
 ;;^UTILITY(U,$J,358.3,1698,2)
 ;;=^5007042
 ;;^UTILITY(U,$J,358.3,1699,0)
 ;;=I05.8^^8^129^10
 ;;^UTILITY(U,$J,358.3,1699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1699,1,3,0)
 ;;=3^Rheumatic Mitral Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,1699,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,1699,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,1700,0)
 ;;=I06.0^^8^129^2
 ;;^UTILITY(U,$J,358.3,1700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1700,1,3,0)
 ;;=3^Rheumatic Aortic Stenosis
 ;;^UTILITY(U,$J,358.3,1700,1,4,0)
 ;;=4^I06.0
 ;;^UTILITY(U,$J,358.3,1700,2)
 ;;=^269573
 ;;^UTILITY(U,$J,358.3,1701,0)
 ;;=I06.1^^8^129^1
 ;;^UTILITY(U,$J,358.3,1701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1701,1,3,0)
 ;;=3^Rheumatic Aortic Insufficiency
 ;;^UTILITY(U,$J,358.3,1701,1,4,0)
 ;;=4^I06.1
 ;;^UTILITY(U,$J,358.3,1701,2)
 ;;=^269575
 ;;^UTILITY(U,$J,358.3,1702,0)
 ;;=I06.2^^8^129^3
 ;;^UTILITY(U,$J,358.3,1702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1702,1,3,0)
 ;;=3^Rheumatic Aortic Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,1702,1,4,0)
 ;;=4^I06.2
 ;;^UTILITY(U,$J,358.3,1702,2)
 ;;=^269577
 ;;^UTILITY(U,$J,358.3,1703,0)
 ;;=I06.8^^8^129^4
 ;;^UTILITY(U,$J,358.3,1703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1703,1,3,0)
 ;;=3^Rheumatic Aortic Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,1703,1,4,0)
 ;;=4^I06.8
 ;;^UTILITY(U,$J,358.3,1703,2)
 ;;=^5007045
 ;;^UTILITY(U,$J,358.3,1704,0)
 ;;=I09.89^^8^129^6
 ;;^UTILITY(U,$J,358.3,1704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1704,1,3,0)
 ;;=3^Rheumatic Heart Diseases
 ;;^UTILITY(U,$J,358.3,1704,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,1704,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,1705,0)
 ;;=I08.8^^8^129^11
 ;;^UTILITY(U,$J,358.3,1705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1705,1,3,0)
 ;;=3^Rheumatic Multiple Valve Dieases NEC
 ;;^UTILITY(U,$J,358.3,1705,1,4,0)
 ;;=4^I08.8
 ;;^UTILITY(U,$J,358.3,1705,2)
 ;;=^5007056
 ;;^UTILITY(U,$J,358.3,1706,0)
 ;;=T82.9XXA^^8^130^2
 ;;^UTILITY(U,$J,358.3,1706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1706,1,3,0)
 ;;=3^Complication of Cardiac/Vascular Prosthetic Device/Implant/Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,1706,1,4,0)
 ;;=4^T82.9XXA
 ;;^UTILITY(U,$J,358.3,1706,2)
 ;;=^5054956
 ;;^UTILITY(U,$J,358.3,1707,0)
 ;;=T82.857A^^8^130^9
 ;;^UTILITY(U,$J,358.3,1707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1707,1,3,0)
 ;;=3^Stenosis of Cardiac Prosthetic Device/Implant/Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,1707,1,4,0)
 ;;=4^T82.857A
